Neuroinflammation in Diseases of the Central Nervous System
中枢神经系统疾病中的神经炎症
基本信息
- 批准号:8837340
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-30 至 2015-09-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlzheimer&aposs DiseaseAnimal ModelAreaAstrocytesBasic ScienceBenchmarkingBiological MarkersBiologyBlood - brain barrier anatomyBrainCSPG4 geneCellsCentral Nervous System DiseasesCollaborationsCommunitiesCytokine ReceptorsDevelopmentDisciplineDiseaseEducational workshopElementsEncephalitisEpidemiologyFundingGeneticHomeostasisHost DefenseImmunologistImmunologyInflammationInflammatoryInjuryKnowledgeLearningMediatingMethodologyMethodsMicrogliaMultiple SclerosisNational Institute of Neurological Disorders and StrokeNerve DegenerationNeuraxisNeurodegenerative DisordersNeurogliaNeurologistNeuronsNeurosciencesNeurosciences ResearchNew MexicoOligodendrogliaOutcomeParaneoplastic SyndromesPatientsReactionReceptor SignalingResearchResearch PersonnelRoleScientistSignal PathwaySignal TransductionSpecific qualifier valueStem cellsStudentsTherapeuticToll-like receptorsTrainingWorkbaseclinical phenotypeclinical practicecytokineforgingmeetingsmicrobialneoplasticnerve stem cellnervous system disorderneuroimmunologyneuroinflammationnovel therapeuticspathogenposterspublic health relevancereceptorresponsesymposiumtissue repair
项目摘要
DESCRIPTION (provided by applicant): Support is requested for a Keystone Symposia meeting entitled Neuroinflammation in Diseases of the Central Nervous System, organized by Richard M. Ransohoff, Christopher K. Glass and V. Hugh Perry. The meeting will be held in Taos, New Mexico from January 25-30, 2015. Neuroinflammation, the response of the central nervous system (CNS) to disturbed homeostasis, typifies all neurological diseases, including primary- inflammatory, developmental, traumatic, ischemic, neoplastic and neurodegenerative. Disease-associated neuroinflammatory responses aren't evolutionarily selected to minimize or repair tissue injury, and may be helpful, harmful or neutral. This Keystone Symposia meeting will: (i) address the developmental roles of neuroinflammatory cells including microglia and blood-brain barrier (BBB) neurovascular elements; (ii) clarify how neuroinflammatory reactions mediate host defense against neuroinvasive microbial pathogens, and also how the response to systemic inflammation affects the neuroinflammatory elements; (iii) specify critically- important neuroinflammatory cells (microglia; astrocytes; NG2+ glia; BBB), receptors (toll-like receptors; inflammasomes; cytokine receptors), signaling pathways and effector mechanisms; and (iv) identify the most salient targets of neuroinflammation (neurons; neural progenitor and stem cells; oligodendroglia) and mechanisms of injury. NINDS is most appropriate to support the meeting because the focus is on diseases of the CNS, i.e. Alzheimer's disease, ALS, encephalitis, paraneoplastic syndromes and Multiple Sclerosis, and because the basic science topics of microglial and astrocyte biology, blood-brain barrier and neuroinflammatory mechanisms, constitute a major focus of NINDS-funded research.
描述(由适用提供):请求支持由Richard M. Ransohoff,Christopher K. Glass和V. Hugh Perry组织的中枢神经系统疾病中的Keystone研讨会会议。会议将于2015年1月25日至30日在新墨西哥州陶斯举行。神经炎症,中枢神经系统(CNS)对干扰稳态的反应,典型的所有神经系统疾病,包括原发性炎症性,发育性,发育性,创伤性,创伤性,缺血性,缺血性,肿瘤性和神经脱发。与疾病相关的神经炎症反应并未进化选择以最大程度地减少或修复组织损伤,并且可能是有益的,有害或中性的。这次Keystone研讨会会议将:(i)解决包括小胶质细胞和血脑屏障(BBB)神经血管元素在内的神经炎性细胞的发育作用; (ii)阐明神经炎症反应如何介导对神经侵袭性微生物病原体的宿主防御,以及对全身炎症的反应如何影响神经炎症元素; (iii)指定至关重要的神经炎性细胞(小胶质细胞;星形胶质细胞; NG2+ Glia; BBB),受体(Toll样受体;炎症;细胞因子受体),信号通路和效应器机制; (iv)确定神经炎症(神经元;神经元祖细胞和干细胞;少突齿)和损伤机制的最显着靶标。 Ninds最适合支持会议,因为重点是中枢神经系统的疾病,即阿尔茨海默氏病,ALS,ALS,脑炎,副塑性综合征和多发性硬化症,以及由于小胶质细胞和星形胶质细胞和星形生物学,血液 - 脑障碍和神经素的基础科学主题,研究的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L. WOODLAND其他文献
DAVID L. WOODLAND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L. WOODLAND', 18)}}的其他基金
Fibrosis: From Basic Mechanisms to Targeted Therapies
纤维化:从基本机制到靶向治疗
- 批准号:
9039836 - 财政年份:2016
- 资助金额:
$ 0.5万 - 项目类别:
Heart Failure: Genetics, Genomics and Epigenetics
心力衰竭:遗传学、基因组学和表观遗传学
- 批准号:
9049783 - 财政年份:2016
- 资助金额:
$ 0.5万 - 项目类别:
Cancer Pathophysiology: Integrating the Host and Tumor Environments
癌症病理生理学:整合宿主和肿瘤环境
- 批准号:
8985958 - 财政年份:2016
- 资助金额:
$ 0.5万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别: